(MENAFN- Investor Brand Network) Cancer is still one of the most prolific killers in the world, accounting for
one in every six deaths
in 2020. Treatment outcomes often depend on the type of cancer and the speed with which it is diagnosed, with some types of cancer being relatively easy to treat and others
having worse health outcomes.
Brain tumors tend to have some of the worse outcomes because they can infect healthy brain tissues, restrict the flow of fluid in the brain, and...
read more>>
NOTE TO INVESTORS:
The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company's newsroom at
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via
investorwire
to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with
bmw prime . As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text“Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information, please visit
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:
BioMedWire (BMW)
San Francisco, California
415.949.5050 Office
BioMedWire is part of the
investorbrandnetwork .
MENAFN25052023000224011066ID1106319746
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.